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Abstract
Background: Rheumatoid arthritis (RA, MIM 180300) is a common and complex inflammatory
disorder. The North American Rheumatoid Arthritis Consortium (NARAC) data, as part of the
Genetic Analysis Workshop 15 data, consists of both genome scan and candidate gene studies on
RA patients.
Results:  We applied the backward genotype-trait association (BGTA) algorithm to capture
marginal and gene × gene interaction effects of multiple susceptibility loci on RA disease status. A
two-stage screening approach was used for the genome scan, whereas a comprehensive study of
all possible subsets was conducted for the candidate genes. For the genome scan, we constructed
an association network among 39 genetic loci that demonstrated strong signals, 19 of which have
been reported in the RA literature. For the candidate genes, we found strong signals for PTPN22
and SUMO4. Based on significant association evidence, we built an association network among the
loci of PTPN22, PADI4, DLG5, SLC22A4, SUMO4, and CARD15. To control for false positives, we
used permutation tests to constrain the family-wise type I error rate to 1%.
Conclusion: Using the BGTA algorithm, we identified genetic loci and candidate genes that were
associated with RA susceptibility and association networks among them. For the first time, we
report possible interactions between single-nucleotide polymorphisms/genes, which may be useful
for biological interpretation.
from Genetic Analysis Workshop 15
St. Pete Beach, Florida, USA. 11–15 November 2006
Published: 18 December 2007
BMC Proceedings 2007, 1(Suppl 1):S13
<supplement> <title> <p>Genetic Analysis Workshop 15: Gene Expression Analysis and Approaches to Detecting Multiple Functional Loci</p> </title> <editor>Heather J Cordell, Mariza de Andrade, Marie-Claude Babron, Christopher W Bartlett, Joseph Beyene, Heike Bickeböller, Robert Culverhouse, Adrienne Cupples, E Warwick Daw, Josée Dupuis, Catherine T Falk, Saurabh Ghosh, Katrina A Goddard, Ellen L Goode, Elizabeth R Hauser, Lisa J Martin, Maria Martinez, Kari E North, Nancy L Saccone, Silke Schmidt, William Tapper, Duncan Thomas, David Tritchler, Veronica J Vieland, Ellen M Wijsman,  Marsha A Wilcox, John S Witte, Qiong Yang, Andreas Ziegler, Laura Almasy and Jean W MacCluer</editor> <note>Proceedings</note> <url>http://www.biomedcentral.com/content/pdf/1753-6561-1-S1-info.pdf</url> </supplement>
This article is available from: http://www.biomedcentral.com/1753-6561/1/S1/S13
© 2007 Ding et al; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Proceedings 2007, 1(Suppl 1):S13 http://www.biomedcentral.com/1753-6561/1/S1/S13
Page 2 of 8
(page number not for citation purposes)
Background
Rheumatoid arthritis (RA) is a heterogeneous disease with
a complex genetic component. Previous studies identified
multiple genetic regions that might be associated with RA.
Amos et al. [1] identified strong linkage evidence on the
major histocompatibility complex (MHC) region, 2q33
(CTLA4) and 11p12 in a genome scan. Plenge et al. [2]
selected 14 genes that may be associated with RA or
related autoimmune disorders and carried out a case-con-
trol study on these candidate genes, with significant
results on PTPN22, CTLA4, and PADI4.
A common approach used in most association studies is
to search, in a marker-by-marker fashion, for loci in asso-
ciation with the disease. This approach precludes consid-
eration of interactions between genetic loci, resulting in
loss of information that is important in understanding
complex traits. On the other hand, consideration of high-
dimensional interactions makes the computational com-
plexity unrealistically high for large-scale studies. To
address these difficulties, Lo and Zheng [3,4] showed the
backward haplotype transmission association (BHTA)
method for case-parent trios to be powerful for studying
complex human disorders because it efficiently uses mul-
tilocus information. The method was extended in the
backward genotype-trait association (BGTA) algorithm
for case-control designs by evaluating association infor-
mation on unphased multilocus genotypes [5]. In this
paper, we applied BGTA to the Illumina genome scan
(studied by Amos et al. [1]) and the candidate gene data
(studied by Plenge et al. [2]) provided by NARAC as part
of Problem 2 of Genetic Analysis Workshop 15.
Methods
Data processing
The Illumina data consist of 5407 single-nucleotide poly-
morphisms (SNPs) genotyped from 642 Caucasian fami-
lies containing 1371 affected siblings with RA [1]. To
apply the BGTA method, we first designated all unaffected
people as our control group (n = 349). For families that
did not contribute a control, we selected one case (n =
474). The level of missing values for the SNPs was <5%.
The candidate gene data consist of 839 cases and 855
unrelated controls [2,6]. Genotypes on 20 SNPs in 14 can-
didate genes were included (Table 1). In Plenge et al. [2],
the candidate gene data were checked for errors (~0.5%)
and were found to be in Hardy-Weinberg equilibrium.
There were 17 SNPs with less than 3% missing data.
rs2240340 (PADI4) had ~65% missing (higher in the con-
trols), which could potentially affect the results, and
rs1061622 and 5509_5511delCAA had ~15% missing
(also higher in the controls). For both data sets, we
imputed the missing genotypes using fastPhase [6].
BGTA screening
Given k SNP markers, there are 3k possible unphased gen-
otypes. The association information score – the genotype-
trait distortion (GTD) statistic – used by BGTA is defined
on the sum of the squared difference between individual
genotype's sample relative frequency among the cases and
the controls, i.e.,
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Table 1: 20 SNPs genotyped on the loci of 14 putative RA candidate genes
SNP Gene Locus
rs2476601 PTPN22 1p13.3–13.1
CT60 CTLA4 2q33
rs1061622 TNFRSF1B 1p36.3–36.2
rs2240340 PADI4 1p36.13
rs6149307 HAVCR1 5q33.2
5509_5511delCAA HAVCR1 5q33.2
IGR2096ms1 IBD5 5q31.1
IGR3084ms1 IBD5 5q31.1
IGR3138ms1 IBD5 5q31.1
rs2073838 SLC22A4 5q31.1
rs31480 IL3 5q31.1
rs2243250 IL4 5q31.1
rs237025 SUMO4 6q25
rs577001 SUMO4 6q25
rs1248696 DLG5 10q23
HugotSNP12ms3 CARD15 16q21
HugotSNP8ms2 CARD15 16q21
HugotSNP13ms2 CARD15 16q21
rs2268277 RUNX1 21q22.3
rs755622 MIF 22q11.23BMC Proceedings 2007, 1(Suppl 1):S13 http://www.biomedcentral.com/1753-6561/1/S1/S13
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the constant (1/nd  + 1/nu)-2, GTD has expectation 1
asymptotically under the null hypothesis of no associa-
tion. If a marker is removed from the studied set, the GTD
score might decrease or increase, thereby reflecting the
contribution of that marker. The genotype-trait associa-
tion (GTA) score for marker M given a current set of mark-
ers is defined as  , where ΔGTD is
the GTD score without M minus the GTD with M, and 
is an adjusting term defined in [5] that makes GTA have
expectation 0 when none of the markers in the subset is
associated with the trait. When M is not associated with
the disease but some of the selected markers are, GTA is
positive, indicating an information gain that occurs when
M (i.e., noise) is removed. If M is associated with the trait,
GTA will be negative, indicating an information loss, and
the magnitude of its value reflects the importance of M.
Based on GTA, BGTA is a backward greedy search algo-
rithm that removes markers that lead to information gain
until no further gain is possible (see the flowchart in Fig-
ure 1). BGTA screening returns a small "optimal" cluster
of markers with the peak GTD score. Herein, a subset is
deemed BGTA-irreducible  if no marker can be removed
without lowering the GTD score. For a large number of
markers, such a backward screening is not informative ini-
tially due to sparseness issues in high dimensions. Thus,
BGTA has been implemented to screen a large number of
random marker subsets [5]. In this paper, GTD scores of
retained local optimal clusters are recorded, which meas-
ure the information content of each retained local opti-
mal cluster. Local optimal clusters of SNPs with GTD score
higher than a selection threshold are selected as impor-
tant.
Two-stage SNP selection
To overcome the computational complexity of analyzing
5407 SNPs while also considering interactions, we devel-
oped a two-stage SNP selection process (see Figure 1 for a
flowchart). We assume that SNPs with high-dimensional
interaction information will show some signal in pairwise
GTD scores (this is an assumption that reduces computa-
tional burden). In Stage 1, we selected 1000 BGTA-irre-
ducible pairs of SNPs with top GTD scores, which also
included 22 SNPs with top marginal GTDs. This yielded
707 unique SNPs for the second stage, where we per-
formed a regular BGTA screening on 700,000 random
subsets of 8 SNPs. For discussion on the size of the subsets
and the number of repeats, see Zheng et al. [5].
Candidate gene study
For the candidate gene set, we evaluated a total of 220 - 1
GTD scores on all possible subsets of 20 SNPs (except for
the empty set) to enumerate GTD's distribution for each
subset size. Then we performed 30,000 greedy BGTA
ni
d ni
u
GTA( ) GTD MA =+ 1
2 Δ 
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Flowchart for the analysis of the genome scan data Figure 1
Flowchart for the analysis of the genome scan data.BMC Proceedings 2007, 1(Suppl 1):S13 http://www.biomedcentral.com/1753-6561/1/S1/S13
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screenings on subsets of 8 SNPs to identify local optimal
BGTA-irreducible SNP clusters.
Selection threshold and evaluation of significance
To estimate the distribution of GTD scores of local opti-
mal BGTA-irreducible SNP clusters under the null hypoth-
esis that no SNP is associated with the trait, we permuted
the labels of disease status to create a simulated data set.
For the two-stage study, we examined the GTD score den-
sity of returned clusters in the second stage from complete
two-stage analyses of 50 permuted data sets. False discov-
ery rate (FDR) was controlled by comparing the observed
real density and the density under the null hypothesis (see
[7-9]). For the candidate gene study, we set the selection
threshold for each SNP subset size to be the maximum
among 100 permuted replicates (the red dotted line in
Figure 2) and identified local optimal BGTA-irreducible
SNP subsets as significant at the 1% family-wise level. The
relatively small number of permutations was due to the
high computational burden of the analytical approach.
This would result in non-trivial margin of error for the sig-
nificance levels evaluated, which needs to be taken into
consideration when interpreting the results.
Association network construction
For subsets identified with more than one SNP, we con-
structed a graphical network using the graph exploration
system GUESS [10] (Figures 3 and 4). A direct edge indi-
cates a two-SNP cluster. For clusters with more than two
SNPs, a non-SNP node was created with all involved SNP
connected to it.
Results and discussion
Genome scan results
From the two-stage screening of the Illumina data, clusters
of SNPs with high GTD scores were returned as important.
Evaluation of significance of in the RA candidategene study Figure 2
Evaluation of significance of in the RA candidategene study. For subsets of a given size, we plotted the highest GTD 
score (red solid line) with a 95% confidence interval (with Bonferroni correction for 220 - 1 multiple comparisons). The top 
GTD scores for sets of two to eight marker sets were significantly higher than the expected value under the null hypothesis 
(black dotted line at 1). Based on 100 permuted data sets, at different subset sizes, the black solid line displays the median max-
imum GTD scores and the vertical bars are the 95% confidence interval of permutations. For each permutation, we also calcu-
lated Bonferroni-corrected 95% confidence intervals for the maximum GTD scores. The blue shading indicates the coverage of 
these 100 confidence intervals at each subset size (the darkest being 0.9 to 1 (or 90 to 100%) and the lightest being 0.0 to 0.1 
(or 0 to 10%)).BMC Proceedings 2007, 1(Suppl 1):S13 http://www.biomedcentral.com/1753-6561/1/S1/S13
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Based on 50 permutations, we estimated the FDR as
described by Storey and Tibshirani [7] at different GTD
levels. Due to the small number of permutations, the esti-
mated FDR has a high level of uncertainty for small FDR
values. Therefore, we set the selection threshold of GTD to
control for FDR at 30% for the association network con-
struction while indicating in Table 2 SNPs with stronger
signals at FDR = 15%. Using the individual clusters, we
built an association network (Figure 3) based on the joint
return clusters of those loci. One central and four satellite
subnetworks are notable, and a number of loci seem to
serve as hubs (e.g., 1p36.22 (PADI4), 2q33.3 (CTLA4),
Genome-wide association network for rheumatoid arthritis Figure 3
Genome-wide association network for rheumatoid arthritis. A different color represents each chromosome.BMC Proceedings 2007, 1(Suppl 1):S13 http://www.biomedcentral.com/1753-6561/1/S1/S13
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5p15.33, 8q24.23, 14q11.2, 14q12, and 18p11.21),
which have a large number of interaction edges with other
loci. The literature suggests that seven out of these eight
loci have previously been found to be associated with sus-
ceptibility to RA. All 39 marker loci in the association net-
work of Figure 3 are listed in Table 2, about half of which
were previously reported in the RA literature. One impor-
tant RA susceptibility gene, PTPN22, was not among these
39 loci, but its signal was right below our selection thresh-
old.
Candidate genes results
For the candidate gene data, we studied all possible sub-
sets of SNPs and identified eight significant BGTA-irreduc-
ible subsets on seven SNPs after controlling for family-
wise type I error. The marginally significant (one-marker
subset) SNPs are rs2476601 (PTPN22), and rs237025 and
rs577001 (both at the locus of SUMO4). The significantly
associated subsets with two or more SNPs represent possi-
ble interactions between these candidate genes in affect-
ing the risk of developing RA. In Figure 4, red edges
indicate interactions involving more than two SNPs,
whereas blue edges indicate pairwise interactions between
two SNPs. As previously identified in [2], we found
PTPN22 and PADI4. However, the SNP at locus PADI4
has a high level of missing values, so results at this locus
should be interpreted with caution.
Tables 3 and 4 illustrate a three-way interaction among
SLC22A4, SUMO4, and CARD15 identified in our results.
Table 3 lists the actual genotype distribution on these
three SNPs (percentages out of 839 cases and 855 controls
that have observed values). Table 4 displays the deviance
table from the logistic regression between the disease sta-
tus and these three SNPs including all possible interac-
tions. Deviance can be directly used as a likelihood-ratio
chi-squared test statistic that evaluates the contribution of
each additional model term (main effect or interaction)
[17]. From the logistic regression, the three-way interac-
tion identified by BGTA is significant even when the main
effects and two-way interaction terms were already
included in the model. More interestingly, only one SNP
at the SUMO4  locus demonstrated a significant main
effect, indicating that contributions from SLC22A4 and
CARD15 are mostly through interactions.
Combining the results from the genome scan and the can-
didate genes results, PTPN22 had the strongest evidence as
an RA susceptibility gene. SLC22A4 also showed up in the
results of both studies.
Table 2: Loci with a high joint GTD score identified in the 
genome scan
Locus Reference
1p36.22 (PADI4)a [1,11,12,2]
1q23.1
2p21a
2p12 [1]
2q12.1a [12]
2q33.1–33.3 (CTLA4)a [1,2]
2q37.3
3q27.2 [14]
4q28.3
4q34.2
5p15.33–15.32a [1]
5q23.1b
6p25.2
6p21 (HLA-DRB1)a OMIM
6q13 [1,11]
6q14.1a [1,11]
6q15 [1,11]
6q16.1–16.2a [1,11]
6q23.2
7q21.3
8p23.1a [13]
8p12
8q24.23a
9q22.2–22.31a
10p15.3–15.2a
10q26.13
11q25
12p13.32–13.31a
12q24.22–24.32
14q11.2a [13]
14q12a [13]
14q32.11–32.2a
15q22.31a [15]
17q25.3a
18p11.21a [16,12]
19q13.43
[16]
20p12.1a [12]
21q21.1 (RUNX1)a OMIM
22q13.33
aMultiple SNPs in LD were found in significant clusters.
bThis locus is 10 Mb away from SLC22A4.
Association network of candidate gene loci with significant  signals Figure 4
Association network of candidate gene loci with significant 
signals.BMC Proceedings 2007, 1(Suppl 1):S13 http://www.biomedcentral.com/1753-6561/1/S1/S13
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Conclusion
In this paper, the BGTA approach was applied to identify
important genetic loci and gene × gene interactions on
susceptibility to RA. Different analytical strategies were
tailored for these two data sets of different nature, illus-
trating the applicability of BGTA and the GTD statistic to
different studies. Using the BGTA method, both marginal
and gene × gene interaction information were extracted
and reflected in the GTD scores. Under a general analytical
framework, both analyses result in association networks
constructed based on gene clusters with significant associ-
ation to RA. To overcome the dimensionality problems of
a genome scan, we imposed a two-stage scheme based on
BGTA screenings. For a small number of candidate genes,
we used GTD directly on subsets of genes to identify clus-
ters that were significantly associated with RA disease sta-
tus. We addressed the multiple comparisons issue using
the most direct permutation-based evaluation and con-
trolled the FDR and the family-wise type I error rate. Both
association networks identified in this paper demon-
strated evidence on gene × gene interaction in affecting
the risk of developing RA. Visualization of these networks
displays interesting structures that could be used to gener-
ate testable biological hypotheses.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Table 4: Logistic regression deviance table and likelihood ratio test results on data shown in Table 3
Modela df Deviance Residual df Residual deviance p-Value from LR test
Null model 1670 2316.23
SLC22A4 2 0.24 1668 2315.99 0.89
SUMO4 2 14.60 1666 2301.39 0.0007b
CARD15 1 0.08 1665 2301.31 0.78
SLC22A4 × SUMO4 4 10.40 1661 2290.92 0.03
SLC22A4 × CARD15 1 0.32 1660 2290.60 0.57
SUMO4 × CARD15 2 1.92 1658 2288.68 0.38
SLC22A4 × SUMO4 × CARD15 2 17.13 1656 2271.54 0.0002
aSNPs analyzed: rs2073838 (SLC22A4), rs577001 (SUMO4), HugotSNP12ms3 (CARD15)
bBold indicates significant p-values.
Table 3: Genotype distributions of identified SNPs on SLC22A4, SUMO4, and CARD15 among cases and controlsa
Percentage among cases or controls
Genotype Cases Controls
1/1, 2/2, 2/3 0 0
1/1, 2/2, 3/3 0 1
1/1, 2/4, 2/3 0 0
1/1, 2/4, 3/3 0 0
1/1, 4/4, 2/3 0 0
1/1, 4/4, 3/3 0 0
1/3, 2/2, 2/3 0 1
1/3, 2/2, 3/3 6 6
1/3, 2/4, 2/3 0 0
1/3, 2/4, 3/3 6 7
1/3, 4/4, 2/3 0 0
1/3, 4/4, 3/3 3 2
3/3, 2/2, 2/3 1 1
3/3, 2/2, 3/3 28 36
3/3, 2/4, 2/3 1 1
3/3, 2/4, 3/3 44 34
3/3, 4/4, 2/3 0 0
3/3, 4/4, 3/3 9 11
aSNPs identified: rs2073838 (SLC22A4), rs577001 (SUMO4), HugotSNP12ms3 (CARD15)BMC Proceedings 2007, 1(Suppl 1):S13 http://www.biomedcentral.com/1753-6561/1/S1/S13
Page 8 of 8
(page number not for citation purposes)
Acknowledgements
This research was supported in part by NIH grant R01 GM070789.
This article has been published as part of BMC Proceedings Volume 1 Sup-
plement 1, 2007: Genetic Analysis Workshop 15: Gene Expression Analysis 
and Approaches to Detecting Multiple Functional Loci. The full contents of 
the supplement are available online at http://www.biomedcentral.com/
1753-6561/1?issue=S1.
References
1. Amos CI, Chen WV, Lee A, Li W, Kern M, Lundsten R, Batliwalla F,
Wener M, Remmers E, Kastner DA, Criswell LA, Seldin MF,
Gregersen PK: High-density SNP analysis of 642 Caucasian
families with rheumatoid arthritis identifies two new linkage
regions on 11p12 and 2q33.  Genes Immun 2006, 7:277-286.
2. Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW,
Wolfe F, Kastner DL, Alfredsson L, Altshuler D, Gregersen PK,
Klareskog L, Rioux JD: Replication of putative candidate-gene
associations with rheumatoid arthritis in >4,000 samples
from North America and Sweden: association of susceptibil-
ity with PTPN22, CTLA4, and PADI4.  Am J Hum Genet 2005,
77:1044-1060.
3. Lo SH, Zheng T: Backward haplotype transmission association
(BHTA) algorithm – a fast multiple-marker screening
method.  Hum Hered 2002, 53:197-215.
4. Lo SH, Zheng T: A demonstration and findings of a statistical
approach through reanalysis of inflammatory bowel disease
data.  Proc Natl Acad Sci USA 2004, 101:10386-10391.
5. Zheng T, Wang H, Lo SH: Backward genotype-trait association
(BGTA)-based dissection of complex traits in case-control
designs.  Hum Hered 2006, 62:196-212.
6. Scheet P, Stephens M: A fast and flexible statistical model for
large-scale population genotype data: applications to infer-
ring missing genotypes and haplotypic phase.  Am J Hum Genet
2006, 78:629-644.
7. Storey JD, Tibshirani R: Statistical significance for genomewide
studies.  Proc Natl Acad Sci USA 2003, 100:9440-9445.
8. Efron B: Large-scale simultaneous hypothesis testing: the
choice of a null hypothesis.  J Am Stat Assoc 2004, 99:96-104.
9. Storey JD: A direct approach to false discovery rates.  J R Statist
Soc B 2002, 64:479-498.
10. Adar E: GUESS: a language and interface for graph explora-
tion.  In CHI'06: Proceedings of the SIGCHI Conference on Human Factors
in Computing Systems New York: ACM Press; 2006:791-800. 
11. John S, Shephard N, Liu G, Zeggini E, Cao M, Chen W, Vasavda N,
Mills T, Barton A, Hinks A, Eyre S, Jones KW, Ollier W, Silman A, Gib-
son N, Worthington J, Kennedy GC: Whole-genome scan, in a
complex disease, using 11,245 single-nucleotide polymor-
phisms: comparison with microsatellites.  Am J Hum Genet
2004, 75:54-64.
12. Osorio YFJ, Bukulmez H, Petit-Teixeira E, Michou L, Pierlot C, Cail-
leau-Moindrault S, Lemaire I, Lasbleiz S, Alibert O, Quillet P, Bardin
T, Prum B, Olson JM, Cornélis F: Dense genome-wide linkage
analysis of rheumatoid arthritis, including covariates.  Arthritis
Rheum 2004, 50:2757-2765.
13. MacKay K, Eyre S, Myerscough A, Milicic A, Barton A, Laval S, Barrett
J, Lee D, White S, John S, Brown MA, Bell J, Silman A, Ollier W,
Wordsworth P, Worthington J: Whole-genome linkage analysis
of rheumatoid arthritis susceptibility loci in 252 affected sib-
ling pairs in the United Kingdom.  Arthritis Rheum 2002,
46:632-639.
14. Fisher SA, Lanchbury JS, Lewis CM: Meta-analysis of four rheuma-
toid arthritis genome-wide linkage studies: confirmation of a
susceptibility locus on chromosome 16.  Arthritis Rheum 2003,
48:1200-1206.
15. Wise CA, Bennett LB, Pascual V, Gillum JD, Bowcock AM: Localiza-
tion of a gene for familial recurrent arthritis.  Arthritis Rheum
2000, 43:2041-2045.
16. Kenealy SJ, Herrel LA, Bradford Y, Schnetz-Boutaud N, Oksenberg JR,
Hauser SL, Barcellos LF, Schmidt S, Gregory SG, Pericak-Vance MA,
Haines JL: Examination of seven candidate regions for multi-
ple sclerosis: strong evidence of linkage to chromosome
1q44.  Genes Immun 2006, 7:73-76.
17. Agresti A: Categorical Data Analysis Hoboken, NJ: John Wiley & Sons, Inc;
2002. 